The global immunoassay market size is estimated to grow by USD 9.4 billion from 2025 to 2029, according to Technavio. The ...

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, has delivered its first Vega systems to Berry Genomics as part of an early access agreement announced in 2022.

Microbix has been a leading producer of purified and inactivated Antigens from native (natural) bacterial and viral organisms for more than three decades. It supplies these critical biological ...

With clinical needs as the core, based on independent research and development of innovative technologies, the company continues to develop products and services suitable for the characteristics ...

MINNEAPOLIS, MN / ACCESSWIRE / January 10, 2025 / Pace® Life Sciences, LLC, a U.S.-based contract research, development, and ...

Vista Gold Corp. (NYSE American and TSX: VGZ) is pleased to provide a summary of its key accomplishments over the past year, ...

The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad's molecular ...

Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, has announced the launch of its new Viral Nucleic Acid Residue Assay Kits (qPCR) to ensure the purity and ...

Globex Mining Enterprises Inc. (T.GMX) hit a new 52-week high of $1.20 Tuesday. Globex reports additional assay results from ...

Analyses of the manufacturer's more extensive data yielded similar results. The assay was reworked as a consequence, but was not removed from other markets during the interim period. NRL ...